Thrombin stimulates production of transforming growth factor-beta by cultured human mesangial cells.
Fibrin formation within the glomeruli occurs in various forms of human and experimental glomerulonephritis and it may play an important role in progressive glomerular injury. Transforming growth factor-beta (TGF-beta) has been shown to participate in the glomerular accumulation of extracellular matrix in glomerulonephritis. We investigated whether thrombin, an important coagulation factor, could modulate the production of TGF-beta by cultured human mesangial cells (HMC). TGF-beta levels in the culture supernatants were measured by ELISA using a specific antibody. The TGF-beta concentration was significantly increased by incubation of HMC with thrombin in a time-dependent manner. The stimulating effect of thrombin on TGF-beta was inhibited by addition of hirudin (a natural thrombin inhibitor) and argatroban (a synthetic thrombin inhibitor). In addition DFP-inactivated thrombin, which has no enzymatic activity, did not stimulate TGF-beta production. A protein kinase C inhibitor (H7) and a tyrosine kinase inhibitor (herbimycin A) also inhibited thrombin induced TGF-beta production. These findings suggested that thrombin may modulate the synthesis of TGF-beta via protein kinase C- and tyrosine kinase-dependent mechanisms in cultured HMC. Thus thrombin may participate in the accumulation of extracellular matrix in glomeruli through the augmentation of TGF-beta production.
Yamabe
H
H
Second Department of Internal Medicine, Hirosaki University School of Medicine, Japan.
Osawa
H
H
Inuma
H
H
Kaizuka
M
M
Tamura
N
N
Tsunoda
S
S
Baba
Y
Y
Shirato
K
K
Onodera
K
K
D002478:Cells, Cultured; D005786:Gene Expression Regulation; D005920:Glomerular Mesangium / Q000378:metabolism*; D006801:Humans; D013917:Thrombin / Q000494:pharmacology*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*
D016212:Transforming Growth Factor beta; D013917:Thrombin